Cargando…

Homoharringtonine regulates the alternative splicing of Bcl-x and caspase 9 through a protein phosphatase 1-dependent mechanism

BACKGROUND: Homoharringtonine (HHT) is a natural alkaloid with potent antitumor activity, but its precise mechanism of action is still poorly understood. METHODS: We examined the effect of HHT on alternative splicing of Bcl-x and Caspase 9 in various cells using semi-quantitative reverse transcripta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Qi, Li, Shiyue, Li, Junjun, Fu, Qiuxia, Wang, Zhongyuan, Li, Bo, Liu, Shan-Shan, Su, Zijie, Song, Jiaxing, Lu, Desheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964699/ https://www.ncbi.nlm.nih.gov/pubmed/29788973 http://dx.doi.org/10.1186/s12906-018-2233-6

Ejemplares similares

Emetine exhibits anticancer activity in breast cancer cells as an antagonist of Wnt/β-catenin signaling
por: Sun, Qi, et al.
Publicado: (2019)

Alternative splicing of BCL-X and implications for treating hematological malignancies
por: Chen, Wanling, et al.
Publicado: (2021)

Homoharringtonine is synergistically lethal with BCL-2 inhibitor APG-2575 in acute myeloid leukemia
por: Wei, Wenwen, et al.
Publicado: (2022)

Specific G-quadruplex ligands modulate the alternative splicing of Bcl-X
por: Weldon, Carika, et al.
Publicado: (2018)

Modulation of the Apoptosis Gene Bcl-x Function Through Alternative Splicing
por: Stevens, Megan, et al.
Publicado: (2019)

Tumor promoter TPA activates Wnt/β-catenin signaling in a casein kinase 1-dependent manner
por: Su, Zijie, et al.
Publicado: (2018)

The RNA-binding protein Sam68 modulates the alternative splicing of Bcl-x
por: Paronetto, Maria Paola, et al.
Publicado: (2007)

Alternative splicing of BCL-x is controlled by RBM25 binding to a G-quadruplex in BCL-x pre-mRNA
por: Le Sénéchal, Ronan, et al.
Publicado: (2023)

Homoharringtonine suppresses imatinib resistance via the Bcl-6/p53 pathway in chronic myeloid leukemia cell lines
por: Wang, Qian, et al.
Publicado: (2017)

Regulation of alternative splicing of Bcl-x by BC200 contributes to breast cancer pathogenesis
por: Singh, R, et al.
Publicado: (2016)

Modulation of Bcl-x Alternative Splicing Induces Apoptosis of Human Hepatic Stellate Cells
por: Wu, Lin, et al.
Publicado: (2016)

Activation of Bcl-2-Caspase-9 Apoptosis Pathway in the Testis of Asthmatic Mice
por: Xu, Wenyuan, et al.
Publicado: (2016)

Longdaysin inhibits Wnt/β-catenin signaling and exhibits antitumor activity against breast cancer
por: Xiong, Yanpeng, et al.
Publicado: (2019)

The Metabolic Signature of AML Cells Treated With Homoharringtonine
por: Zhang, Yulong, et al.
Publicado: (2022)

Homoharringtonine and omacetaxine for myeloid hematological malignancies
por: Lü, Shuqing, et al.
Publicado: (2014)

Homoharringtonine combined with aclarubicin and cytarabine synergistically induces apoptosis in t(8;21) leukemia cells and triggers caspase‐3‐mediated cleavage of the AML1‐ETO oncoprotein
por: Cao, Jiang, et al.
Publicado: (2016)

Salinomycin exerts anti‐colorectal cancer activity by targeting the β‐catenin/T‐cell factor complex
por: Wang, Zhongyuan, et al.
Publicado: (2019)

Mimicking Cdk2 phosphorylation of Bcl-xL at Ser73 results in caspase activation and Bcl-xL cleavage
por: Seng, NS, et al.
Publicado: (2016)

Aberrant Bcl-x splicing in cancer: from molecular mechanism to therapeutic modulation
por: Dou, Zhihui, et al.
Publicado: (2021)

Relative strength of 5’ splice-site strength defines functions of SRSF2 and SRSF6 in alternative splicing of Bcl-x pre-mRNA
por: Choi, Namjeong, et al.
Publicado: (2021)

Correction: Promoter choice influences alternative splicing and determines the balance of isoforms expressed from the Mouse bcl-X gene
por: Pecci, Adali, et al.
Publicado: (2021)

Synergistic efficacy of homoharringtonine and venetoclax on acute myeloid leukemia cells and the underlying mechanisms
por: Yuan, Fangfang, et al.
Publicado: (2022)

Gigantol inhibits Wnt/β-catenin signaling and exhibits anticancer activity in breast cancer cells
por: Yu, Shubin, et al.
Publicado: (2018)

Bcl-2–regulated apoptosis and cytochrome c release can occur independently of both caspase-2 and caspase-9
por: Marsden, Vanessa S., et al.
Publicado: (2004)

The Natural Compound Homoharringtonine Presents Broad Antiviral Activity In Vitro and In Vivo
por: Dong, Hui-Jun, et al.
Publicado: (2018)

Characterization of the Newly Established Homoharringtonine- (HHT-) Resistant Cell Lines and Mechanisms of Resistance
por: Li, Fenglin, et al.
Publicado: (2022)

Homoharringtonine enhances the effect of imatinib on chronic myelogenous leukemia cells by downregulating ZFX
por: Wu, Jingjing, et al.
Publicado: (2019)

Dentatin Induces Apoptosis in Prostate Cancer Cells via Bcl-2, Bcl-xL, Survivin Downregulation, Caspase-9, -3/7 Activation, and NF-κB Inhibition
por: Arbab, Ismail Adam, et al.
Publicado: (2012)

Novel Antiviral Activities of Obatoclax, Emetine, Niclosamide, Brequinar, and Homoharringtonine
por: Andersen, Petter I., et al.
Publicado: (2019)

Synergistic Lethality Effects of Apatinib and Homoharringtonine in Acute Myeloid Leukemia
por: Shi, Yuanfei, et al.
Publicado: (2022)

Regulation of BCL-X splicing reveals a role for the polypyrimidine tract binding protein (PTBP1/hnRNP I) in alternative 5′ splice site selection
por: Bielli, Pamela, et al.
Publicado: (2014)

Bcl-xL overexpression decreases GILZ levels and inhibits glucocorticoid-induced activation of caspase-8 and caspase-3 in mouse thymocytes
por: Muscari, Isabella, et al.
Publicado: (2020)

Mitochondrial Bcl-xL promotes brain synaptogenesis by controlling non-lethal caspase activation
por: Nguyen, Trang Thi Minh, et al.
Publicado: (2023)

Functional Consequences for Apoptosis by Transcription Elongation Regulator 1 (TCERG1)-Mediated Bcl-x and Fas/CD95 Alternative Splicing
por: Montes, Marta, et al.
Publicado: (2015)

Biophysical characterisation of the Bcl-x pre-mRNA and binding specificity of the ellipticine derivative GQC-05: Implication for alternative splicing regulation
por: Bhogadia, Mohammed, et al.
Publicado: (2022)

The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemia
por: Li, Xia, et al.
Publicado: (2017)

Homoharringtonine Exerts Anti-tumor Effects in Hepatocellular Carcinoma Through Activation of the Hippo Pathway
por: Wang, Haina, et al.
Publicado: (2021)

Homoharringtonine promotes BCR-ABL degradation through the p62-mediated autophagy pathway
por: Li, Su, et al.
Publicado: (2020)

WDR54 exerts oncogenic roles in T‐cell acute lymphoblastic leukemia
por: Li, Huan, et al.
Publicado: (2023)

Homoharringtonine Exerts an Antimyeloma Effect by Promoting Excess Parkin-Dependent Mitophagy
por: Zhang, Yanyu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0hunns0l9tik16jd3sc9ouhadh